DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice No. 09/2025-26, dated July 22, 2025.

As per the latest trade notice, the revised deadline for submission of applications for obtaining Export Authorisation has been extended to July 31, 2025. This extension follows the earlier communication under Trade Notice No. 06/2025-26 issued on June 18, 2025, which had originally set the deadline.

The notice stated that “In continuation to the earlier Trade Notice No. 06/2025-26 dated June 18, 2025, the last date for submission of application for Export Authorisation for Pharma Grade Sugar, has been extended up to July 31, 2025. All other contents of the Trade Notice remains unchanged.”

Comprehensive Guide of Law and Procedure for Filing of Income Tax Appeals, Click Here

According to the directorate, all other terms and conditions mentioned in the earlier notice are still in effect. With the high standards and sensitive nature of exporting pharmaceutical-grade sugar, the delay is meant to provide exporters more time to finish the required paperwork and regulatory compliance.

This announcement has been circulated to all Regional Authorities of DGFT, Customs Commissionerates, and members of the trade community. For any further clarification, stakeholders have been advised to contact the DGFT.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit